Your browser doesn't support javascript.
loading
Detailed Clinical Characteristics, Interventions, and Long-Term Outcomes of Patients With Gastric Cancer Who Received the Best Supportive Care Without Any Anticancer Treatment.
Arihara, Yohei; Shibuya, Ryo; Ono, Michihiro; Suzuki, Norito; Omori, Ginji; Ikeda, Yuki; Nakamura, Hajime; Yamada, Michiko; Abe, Tomoyuki; Takada, Kohichi; Maeda, Masahiro.
Afiliación
  • Arihara Y; Department of Gastroenterology, Steel Memorial Muroran Hospital, Hokkaido, Japan.
  • Shibuya R; Department of Medical Oncology, Sapporo Medical University School of Medicine, Hokkaido, Japan.
  • Ono M; Department of Gastroenterology, Steel Memorial Muroran Hospital, Hokkaido, Japan.
  • Suzuki N; Department of Medical Oncology, Sapporo Medical University School of Medicine, Hokkaido, Japan.
  • Omori G; Department of Pancreatobiliary Medicine, Steel Memorial Muroran Hospital, Hokkaido, Japan.
  • Ikeda Y; Department of Gastroenterology, Steel Memorial Muroran Hospital, Hokkaido, Japan.
  • Nakamura H; Department of Medical Oncology, Sapporo Medical University School of Medicine, Hokkaido, Japan.
  • Yamada M; Department of Gastroenterology, Steel Memorial Muroran Hospital, Hokkaido, Japan.
  • Abe T; Department of Medical Oncology, Sapporo Medical University School of Medicine, Hokkaido, Japan.
  • Takada K; Department of Pancreatobiliary Medicine, Steel Memorial Muroran Hospital, Hokkaido, Japan.
  • Maeda M; Department of Medical Oncology, Sapporo Medical University School of Medicine, Hokkaido, Japan.
Palliat Med Rep ; 4(1): 334-338, 2023.
Article en En | MEDLINE | ID: mdl-38098858
ABSTRACT

Background:

Due to the lack of studies, the long-term prognoses of unfit patients with gastric cancer (GC) who did not receive any aggressive cancer treatment (best supportive care [BSC] cases) remain unclear, especially for those with potentially curable GC. We conducted this observational study to capture the real-world data of characteristics and outcomes for BSC cases.

Method:

Consecutive clinical records of patients with GC diagnosed at Steel Memorial Muroran Hospital from January 2017 to December 2021 were analyzed.

Result:

Of 481 patients diagnosed with GC, 91 (18.9%) were BSC cases. The median overall survival (OS) was 12.4, 8.3, and 2.5 months for clinical stage (cStage) I, II-III, and IV, respectively. Patients with potentially curable GC (cStage I-III) had significantly longer OS than those with incurable disease (cStage IV), with a hazard ratio for death of 0.29 (95% confidence interval 0.18-0.47).

Conclusion:

Our report provides useful information for decision-making for unfit patients with GC in daily clinical practice.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Palliat Med Rep Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Palliat Med Rep Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos